IBO_OUT_1 [2025-04-01 07:12:38 -0400] 2576 Bytes | 738 tokens | Cum: 738 tkns (9.22% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Impact BioMedical (IBO) which is at 1.03 up from 0.87. So, I pulled together a bunch of data for you to look over real fast. It's still early, 7:12:37 AM on Tue Apr 01, 2025 -0400. So, what's the verdict? You're the expert!

Here's the first list of news for Impact BioMedical:

C1 - Mar-21-25 02:38PM - Impact Biomedical Inc. Announcement Stock Activity/Pricing
C2 - Feb-26-25 08:30AM - Impact Biomedical Inc. Announces Acquisition of Celios , Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality
C3 - Feb-26-25 08:30AM 08:30AM - DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
C4 - Jan-23-25 04:30PM - Impact BioMedical Inc. to Present at The Microcap Conference
C5 - Nov-19-24 08:00AM - Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
C6 - Nov-18-24 07:00AM - Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthroughs
C7 - Nov-11-24 07:30AM - Positioned for Growth: Impact BioMedical Inc.'s (NYSEAmerican: IBO) Push into Cancer and Immune Health
C8 - Oct-15-24 06:00AM - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker Technology Targeting Inflammatory Disease

Prior AI Reports for IBO:
1. 2025-03-21 – Score: 92 – Target: 6.2000 – Highs: 6.1700 / 4.5000 / 4.10
impact-biomedical-soars-despite-sales-drop-targets-50-price-increase
2. 2025-03-20 – Score: 70 – Target: 2.5000 – Highs: 2.4800 / 6.1700 / 4.50
impact-biomedical-shows-mixed-performance-amid-high-investor-interest

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Impact BioMedical (IBO)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

IBO_OUT_3 [2025-04-01 07:12:42 -0400] 1099 Bytes | 320 tokens | Cum: 1060 tkns (13.25% of 8k)
==========================================================================

Showing C2 (chunk 1 of 4): C2:
**Impact Biomedical Inc. Announces Acquisition of Celios , Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality**
Date: Feb-26-25 08:30AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/02/26/3032920/0/en/Impact-Biomedical-Inc-Announces-Acquisition-of-Celios-Protecting-People-Plants-and-Animals-from-the-World-s-Most-Dangerous-Pathogens-With-Clean-Room-Air-Quality.html

February 26, 2025 08:30 ET| Source:IMPACT BIOMEDICAL INCIMPACT BIOMEDICAL INC

HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced the acquisition of Celios®, a pioneering air purification technology company, in a strategic, all equity transaction valued at approxi

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

IBO_OUT_5 [2025-04-01 07:12:43 -0400] 997 Bytes | 297 tokens | Cum: 1440 tkns (18.00% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T17:05:39Z - 12 Health Care Stocks Moving In Monday's Intraday Session - ABVC BioPharma (NASDAQ:ABVC), bluebird b...
A2 - 2025-03-28T21:28:06Z - DSS Inc. sells $1.95 million worth of Impact Biomedical shares By Investing.com...
A3 - 2025-03-28T21:28:05Z - DSS Inc. sells $1.95 million worth of Impact Biomedical shares By Investing.com...
A4 - 2025-03-28T17:05:40Z - 12 Health Care Stocks Moving In Friday's Intraday Session - DBV Technologies (NASDAQ:DBVT), Impact B...
A5 - 2025-03-26T21:05:44Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - Acrivon Therapeutics (NASDAQ:ACRV...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

IBO_OUT_7 [2025-04-01 07:12:49 -0400] 1098 Bytes | 340 tokens | Cum: 1782 tkns (22.27% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Monday's Intraday Session - ABVC BioPharma (NASDAQ:ABVC), bluebird bio (NASDAQ:BLUE)**Date: 2025-03-31Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44567209/12-health-care-stocks-moving-in-mondays-intraday-sessionGainers Corcept Therapeutics CORT stock moved upwards by 88.8% to $103.12 during Monday's regular session. The market value of their outstanding shares is at $10.8 billion. Regencell Bioscience RGC stock increased by 38.2% to $35.48. The company's market cap stands at $461.6 million. Citius Oncology CTOR shares rose 34.34% to $0.89. The market value of their outstanding shares is at $63.9 million. bluebird bio BLUE shares rose 26.41% to $5.16. The market value of their outstanding shares is at $50.2 million. The company's, Q4 earnings came out 2 days ago. WORK Medi

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

IBO_OUT_9 [2025-04-01 07:12:49 -0400] 1055 Bytes | 314 tokens | Cum: 2249 tkns (28.11% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-21T18:38:00Z - Impact Biomedical Inc. Announcement Stock Activity/Pricing
B2 - 2025-02-26T13:30:00Z - Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"
B3 - 2024-12-12T20:56:00Z - Contractor Wins Prestigious Award for Exquisite Ornamental Staircase
B4 - 2024-10-25T11:00:00Z - ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at EMUC 2024
B5 - 2024-10-15T10:00:00Z - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
B6 - 2024-09-17T15:29:05Z - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

IBO_OUT_11 [2025-04-01 07:12:52 -0400] 653 Bytes | 172 tokens | Cum: 2423 tkns (30.29% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Impact Biomedical Inc. Announcement Stock Activity/Pricing**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/21/3047292/0/en/Impact-Biomedical-Inc-Announcement-Stock-Activity-Pricing.htmlImpact BioMedical Inc. announced that there has been no material development in its business affairs not previously disclosed or any other reason to account for the unusual market action regarding its share price.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

IBO_OUT_13 [2025-04-01 07:12:52 -0400] 1093 Bytes | 283 tokens | Cum: 2759 tkns (34.49% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S2 - 2025-03-28 8-K Item 1.01. Entry Into a Material Definitive Agrmt.

Debt Conversion Agrmt

As previously reported, Impact BioMedical Inc. (the Company) entered into a Debt Conversion Agrmt, dated March 24, 2025, with DSS, Inc., pursuant to that certain Amended and Restated Promisso...

S3 - 2025-03-28 10-K ITEM 7 - MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

FORWARD-LOOKING STATEMENTS

Certain statements contained herein this report constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act o...

S4 - 2025-01-29 8-K Item 7.01 Regulation FD Disclosure

Frank D. Heuszel, the Companys Chf Exec Off, provided certain investor information, commencing on January 29, 2025. The slide package prepared by the Company for use in connection with these presentations is furnished herewith as Ex...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

IBO_OUT_15 [2025-04-01 07:12:59 -0400] 1080 Bytes | 303 tokens | Cum: 3064 tkns (38.30% of 8k)
==========================================================================

Showing S2 (chunk 1 of 1): S2:
Item 1.01. Entry Into a Material Definitive Agreement.

Debt Conversion Agreement

As previously reported, Impact BioMedical Inc. (the Company) entered into a Debt Conversion Agreement, dated March 24, 2025, with DSS, Inc., pursuant to that certain Amended and Restated Promissory Note, dated September 16, 2024 (the Promissory Note). The original principal amount of the Promissory Note was $12,000,000, and as of March 24, 2025, the Promissory Note had a principal balance of $13,176,477.03.

In connection with the above, the Company and DSS have agreed to settle a portion of the outstanding indebtedness under the Promissory Note in the amount of $8,697,142.80 through the issuance of 2,415,873 shares of the Companys common stock, at a conversion ratio of $3.60 per share, which was equal to the closing market price of the Companys common stock on March 24, 2025....

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

IBO_OUT_17 [2025-04-01 07:13:07 -0400] 4547 Bytes | 1317 tokens | Cum: 4532 tkns (56.65% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+-------------------------+
| Volume: 1,334,208 | Perf Month: -44.94% | Option/Short: No / Yes | Sales Y/Y TTM: -100.00% |
+--------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 3.18M | Perf Quarter: -45.63% | Short Float: 0.17% | ROE: -167.65% |
+--------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 0.42 | Index: - | Short Ratio: 0.00 | ROI: -580.23% |
+--------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 43.07 | Market Cap: 10.01M | Short Interest: 0.01M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 0.80 | Shs Outstand: 11.50M | Beta: - | EPS Surprise: - |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA20: -43.73% | Shs Float: 5.16M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA50: -49.79% | Inst Own: 0.77% | Sales past 5Y: 0.00% | Earnings: - |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA200: -55.26% | Insider Own: 55.15% | Employees: 2 | |
+--------------------+-----------------------+------------------------+-------------------------+
| Perf Week: -75.83% | Insider Trans: -9.46% | Debt/Eq: 2.08 | |
+--------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: IMPACT BIOMEDICAL INC. (IBO) by DSS, INC. (Unknown Title) on 2025-03-21
- Common Stock: 166600 shares at $3.3004 (I)
- Common Stock: 166600 shares at $3.3004 (I)
- Common Stock: 166600 shares at $3.3004 (I)
- Common Stock: 48281 shares at $3.1292 (D)
- Common Stock: 9858 shares at $3.15 (D)
- Common Stock: 47681 shares at $2.5011 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -24770000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.87
Average Volume: 9042023.14
30-Day High: 4.96
30-Day Low: 0.53

[Detailed Financials: TTM 2024]
- Total Assets: $20,290,000.0
- Total Liabilities: $13,053,000.0
- Total Equity: $7,237,000.0
- Current Assets: $2,448,000.0
- Current Liabilities: $9,785,000.0

[Income Statement: TTM 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.3

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $1,998,000.0

[Detailed Financials: FY 2024]
- Total Assets: $20,290,000.0
- Total Liabilities: $13,053,000.0
- Total Equity: $7,237,000.0
- Current Assets: $2,448,000.0
- Current Liabilities: $9,785,000.0

[Income Statement: FY 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.3

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $1,998,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

IBO_OUT_19 [2025-04-01 07:13:11 -0400] 676 Bytes | 167 tokens | Cum: 4909 tkns (61.36% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

IBO_IN_21 [2025-04-01 07:13:11 -0400] 126 Bytes | 29 tokens | Cum: 5033 tkns (62.91% of 8k)
==========================================================================

====================================
[2025-04-01 07:13:11] # Analysis Completed
Elapsed Time: 34.14 seconds